Folgen
Philippe Blache
Philippe Blache
Directeur de Recherche CNRS
Bestätigte E-Mail-Adresse bei inserm.fr - Startseite
Titel
Zitiert von
Zitiert von
Jahr
SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes
P Blache, M Van De Wetering, I Duluc, C Domon, P Berta, JN Freund, ...
The Journal of cell biology 166 (1), 37-47, 2004
5932004
Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium
P Bastide, C Darido, J Pannequin, R Kist, S Robine, C Marty-Double, ...
The Journal of cell biology 178 (4), 635-648, 2007
5842007
Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells
C Darido, M Buchert, J Pannequin, P Bastide, H Zalzali, T Mantamadiotis, ...
Cancer research 68 (11), 4258-4268, 2008
1352008
Oxyntomodulin-like immunoreactivity: diurnal profile of a new potential enterogastrone.
A Le Quellec, A Kervran, P Blache, AJ Ciurana, D Bataille
The Journal of Clinical Endocrinology & Metabolism 74 (6), 1405-1409, 1992
1161992
KLF4 regulation in intestinal epithelial cell maturation
M Flandez, S Guilmeau, P Blache, LH Augenlicht
Experimental cell research 314 (20), 3712-3723, 2008
952008
Distribution of Oxyntomodulin and Glucagon in the Gastrointestinal Tract and the Plasma of the Rat*
A Kervran, P Blache, D Bataille
Endocrinology 121 (2), 704-713, 1987
911987
Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells
P Jay, P Berta, P Blache
Cancer research 65 (6), 2193-2198, 2005
812005
SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling
BP Prévostel C, Rammah-Bouazza C, Trauchessec H, Canterel-Thouennon L ...
oncotarget, 2016
632016
Oxyntomodulin and Glicentin: Brain-Gut Peptides in the Rat*
P Blache, A Kervran, D Bataille
Endocrinology 123 (6), 2782-2787, 1988
561988
Oxyntomodulln and glic~ ntlnlbrain gut peptides in the rat
P Blache
Endocrinology I 23, 1988
561988
CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium
H Zalzali, C Naudin, P Bastide, C Quittau-Prevostel, C Yaghi, F Poulat, ...
Oncogene 27 (56), 7131-7138, 2008
542008
Cloning and tissue distribution of a new rat olfactory receptor-like (OL2)
P Blache, L Gros, G Salazar, D Bataille
Biochemical and biophysical research communications 242 (3), 669-672, 1998
521998
Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase.
P Blache, A Kervran, M Dufour, J Martinez, D Le-Nguyen, S Lotersztajn, ...
Journal of Biological Chemistry 265 (35), 21514-21519, 1990
521990
Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney
A Kervran, M Dubrasquet, P Blache, J Martinez, D Bataille
Regulatory peptides 31 (1), 41-52, 1990
501990
MiniSOX9, a dominant-negative variant in colon cancer cells
R Abdel-Samad, H Zalzali, C Rammah, J Giraud, C Naudin, S Dupasquier, ...
Oncogene 30 (22), 2493-2503, 2011
472011
Molecular cloning and tissue distribution of rat sarcosine dehydrogenase
F Bergeron, A Otto, P Blache, R Day, L Denoroy, R Brandsch, D Bataille
European Journal of Biochemistry 257 (3), 556-561, 1998
471998
Miniglucagon (glucagon 19–29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway
S Dalle, P Smith, P Blache, D Le-Nguyen, L Le Brigand, F Bergeron, ...
Journal of Biological Chemistry 274 (16), 10869-10876, 1999
461999
CELL BIOLOGY AND METABOLISM-Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway
S Dalle, P Smith, P Blache, D Le-Nguyen, LL Brigand, F Bergeron, ...
Journal of Biological Chemistry 274 (16), 10869-10876, 1999
46*1999
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon
C Pavoine, V Brechler, A Kervran, P Blache, D Le-Nguyen, S Laurent, ...
Am J Physiol 260 (5 Pt 1), C993-C999, 1991
431991
Inhibition of gastric acid secretion by oxyntomodulin and its 19-W fragment in the conscious rat
C Jarrousse, C Carles-Bonnet, H Niel, R Sabatier, MP Audousset-Puech, ...
371993
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20